Caliper Technologies - CALP Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Caliper Technologies - CALP

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (95)	7/13/2005 3:28:02 PM
From: tuck	of 114

>>HOPKINTON, Mass. (AP) -- Caliper Life Sciences Inc., a maker of drug discovery tools and medical tests, said Tuesday that it expects to hit the high end of its second-quarter revenue guidance, and reaffirmed estimates for the full year. The company said quarterly revenue should come in at the high end of the $17 million to $20 million range, and still sees full-year revenue of $84 million to $90 million. Analysts surveyed by Thomson Financial are looking for sales of $18.8 million and $85.7 million for the quarter and year, respectively. Caliper also said it granted a non-exclusive license for its microfluidics patents to Agilent Technologies Inc., a maker of scientific instruments and analysis equipment. The license covers Agilent's use of Caliper's LabChip technology, a testing system of tiny channels built into a biochip that can perform thousands of experiments on a sample. The company will supply biochips to Agilent -- which will use the technology in its 2100 Bioanalyzer testing system -- for the next five years. Agilent will pay an upfront licensing fee and royalties on products covered by the agreement. Financial details were not disclosed. Caliper shares rose 20 cents, or 3.4 percent, to $6.10 in afternoon trading on the Nasdaq, and Agilent shares rose 10 cents to $25.77 on the New York Stock Exchange.<< Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next